| Feb 24, 2026 | Axelera | $250.0M Other Equity | Rogier Ketelaars | Val Vavilov, BlackRock, Alessandro Scortecci, Svetoslava Georgieva, David Goldschmidt, Alan Vandenberghe, Ivo Tzenov, Verve Investments |
| Sep 15, 2025 | Bloomlife | $7.5M Other Equity | — | Gather Ventures, NextGen Venture Partners |
| Sep 4, 2025 | MRM Health | $64.1M Series B | Jean-Patrick Hennebelle | Raf Moons, Goedele Ertveldt, Ackermans & van Haaren, Julian Zachmann, OMX Ventures, Qbic II |
| Apr 18, 2024 | Cognivia | $16.5M Other Equity | — | Vesalius Biocapital IV, We Venture Capital |
| Mar 12, 2024 | MICLEDI Microdisplays | $30.0M Series A | — | imec, imec.xpand, KBC, PMV |
| Sep 1, 2023 | AbolerIS Pharma | $29.0M Series A | Caixa Capital | BioVentures Investors, Newton Biocapital, Sambrinvest, Sound Bioventures, Sudinvest, Turenne Capital, Wallonie Entreprendre |
| Jul 1, 2023 | Aphea.Bio | $77.0M Series C | Caaj Greebe | Astanor Ventures, Energy Impact Partners, AIF, Bill & Melinda Gates Foundation, BNP Paribas Fortis Private Equity, David Devigne |
| Jun 7, 2023 | Santero Therapeutics | $8.6M Series A | Philippe De Backer, Newton Biocapital | Sambrinvest, Wallonie Entreprendre |
| Oct 25, 2022 | Axelera | $33.7M Grant / Series A | Sander Verbrugge | Cyril Vancura, RVO, Marc Ceurremans |
| Aug 25, 2022 | Magnax | $19.9M Other Equity | BIG Capital | — |
| Dec 6, 2021 | PDC*line Pharma | $26.2M Grant / Series B | Sangwoo Lee | Alpha Holdings, Brain Asset Management, Hansongneotech, Noshaq, Sambrinvest, Fontaine François, Smart Korea UTC Bio-Healthcare Venture Fund, SRIW, Walloon Region |
| May 24, 2021 | ExeVir Bio | $50.0M Series A | Philippe Monteyne | Belgian family offices, Noshaq, Sambrinvest, Stef HEYLEN, MD, Caroline THIELEN, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet, Joël Henneghien |
| Feb 17, 2021 | Imcyse | $25.8M Series B Extension | — | Biogenosis, Epimede, KU Leuven, LSP, Noshaq, Pfizer, SRIW |
| Jan 19, 2021 | Endo Tools Therapeutics | $9.7M Series D | Michel BAIJOT | Chagral Invest, Epim 'e8de |
| Sep 2, 2020 | Miracor Medical SA | $28.5M Series E | — | Earlybird, Noshaq, Quest for Growth, SRIW, Yonghua Capital |
| Jul 28, 2020 | ExeVir Bio | $27.0M Other Equity | Philippe Monteyne | Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet |
| Feb 14, 2020 | OncoDNA | $20.6M Series B | Robert Schier, Guy Geldhof | CPH Bank, Inventures, Sambrinvest, Fontaine François, Sofinim, SRIW |
| Jan 22, 2020 | PDC*line Pharma | $15.4M Series B | — | Financière Spin-off Luxembourgeoise, Sangwoo Lee, Noshaq, Sambrinvest, Shinhan-Cognitive Start-up Fund, UTC 2019 BIOVENTUREFUND |
| Sep 1, 2019 | iSTAR Medical | $44.0M Series C | Bram Vanparys, PhD, MBA, Anne Portwich | EQT Life Sciences, BNP Paribas Fortis Private Equity, Capricorn Venture Partners, Lionel Carnot, SRIW |
| Jul 4, 2019 | Unifly | $19.2M Series B | — | Professor Klaus-Dieter Scheurle, PMV, Qbic, Terra Drone |
| Jun 18, 2019 | Imcyse | $38.8M Debt / Grant / Series B | LSP | Belfius, Biogenosis, DGO6, Marc Moles le Bailly, Paul Van Dun, Marc Foidart, Fontaine François, Franssen Christina |
| Feb 11, 2019 | Endo Tools Therapeutics | $5.7M Series C | Epim 'e'de | Chagral Invest |
| Feb 19, 2018 | Synergia Medical | $10.1M Series A | Alain Parthoens | Pierre Detrixhe, SRIW |
| Nov 17, 2017 | Ncardia | $12.4M Series B | Marc Foidart | InnovationQuarter, Sambrinvest, SRIW, Vesalius Biocapital |
| Apr 1, 2017 | Ncardia | $2.7M Other Equity | — | Sambrinvest |
